The U.S. @DeptofDefense has awarded @Novavax $60M to fund manufacture of 10 million doses of its COVID-19 vaccine candidate NVX-CoV2373 for use in phase II/III trials, or under an Emergency Use Authorization, if approved by @US_FDA.
"Don't worry about the world coming to an end today. It's already tomorrow in Australia"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.